作为术后肝功能衰竭的预测因素的瘤性2的可溶性抑制

Jing Wu1, Shadike Apaer1, Xiapukaiti Fulati1

  • 1Department of Liver Transplantation & Laparoscopic Surgery, Digestive & Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.

BJS open
|June 27, 2024
PubMed
概括

肝切除后瘤性2 (sST2) 升高的可溶性抑制可以预测肝切除后的肝衰竭. 在术后第一天使用sST2的早期检测提供了一种可靠的方法来识别高风险患者.